European equities traded in the US as American depositary receipts started the week off lower late Monday morning, declining 0.35% to 1,925.58 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and software firm SAP (SAP), which rose 4% and 3.3%, respectively. They were followed by telecommunications company Ericsson (ERIC) and 3D printer company Materialise (MTLS), which were up 2.5% and 2.4%, respectively.

The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and brewing company Anheuser-Busch InBev (BUD), which dropped 2.8% and 2.4%, respectively. They were followed by oil and gas company Eni (E) and biopharmaceutical company argenx (ARGX), which were down 2.2% and 1.9%, respectively.

The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which advanced 30% and 6.8%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company NuCana (NCNA), which increased 5.9% and 3%, respectively.

The decliners from the UK and Ireland were led by pharmaceutical company AstraZeneca (AZN) and biotech firm Trinity Biotech (TRIB), which fell 8.1% and 2.9%, respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Akari Therapeutics (AKTX), which lost 2.3% and 2.1%, respectively.